Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis-Reference-Cited by-同舟云学术

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis

Published:2014-09-04 Issue:1 Volume:28 Page:44-50
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Mukai Shoichiro,Yorita Kenji,Kawagoe Yukari,Katayama Yuichi,Nakahara Kozue,Kamibeppu Toyoharu,Sugie Satoru,Tukino Hiromasa,Kamoto Toshiyuki,Kataoka Hiroaki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

http://link.springer.com/content/pdf/10.1007/s13577-014-0101-3.pdf

Reference24 articles.

1. Sahi C, Knox JJ, Clemons M, Joshua AM, Broom R. Renal cell carcinoma bone metastases: clinical advances. Ther Adv Med Oncol. 2010;2:75–83.

2. Beuselinck B, Oudard S, Rixe O, et al. Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol. 2011;22:794–800.

3. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutation in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 1997;16:68–73.

4. Foster K, Prowse A, van den Berg A, et al. Somatic mutation of the von Hippel–Lindau disease tumor suppressor gene in non-familial clear-cell renal cell carcinoma. Hum Mol Genet. 1994;3:2169–73.

5. Betsunoh H, Mukai S, Akiyama Y, Fukushima T, Minamiguchi N, Hasui Y, Osada Y, Kataoka H. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. Cancer Sci. 2007;98:491–8.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review;Cancer Treatment Reviews;2024-09

2. Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus;Cell;2024-08

3. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID;npj Science of Food;2024-03-30

4. Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus;2024-02-22

5. Mechanism of the Covalent Inhibition of Human Transmembrane Protease Serine 2 as an Original Antiviral Strategy;The Journal of Physical Chemistry B;2023-07-10